脳損傷(Brain Injury)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Brain Injury Overview 6
Therapeutics Development 7
Pipeline Products for Brain Injury – Overview 7
Pipeline Products for Brain Injury – Comparative Analysis 8
Brain Injury – Therapeutics under Development by Companies 9
Brain Injury – Therapeutics under Investigation by Universities/Institutes 10
Brain Injury – Pipeline Products Glance 11
Early Stage Products 11
Brain Injury – Products under Development by Companies 12
Brain Injury – Products under Investigation by Universities/Institutes 13
Brain Injury – Companies Involved in Therapeutics Development 14
Acorda Therapeutics, Inc. 14
Biogen Idec Inc. 15
Chiesi Farmaceutici SpA 16
Faron Pharmaceuticals Oy 17
Virogenomics, Inc. 18
Brain Injury – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 25
Drug Profiles 26
Enzyme to Inhibit Chondroitin Sulfate Proteoglycan for Spinal Cord Injury and Brain Injury – Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
interferon beta-1a – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Peptide to Inhibit Pannexin-1 for Brain Injury – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
PRE-084 – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Recombinant Interleukin-34 to Agonize GM-CSFR for Alzheimer’s Disease and Brain Injury – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Recombinant Protein to Agonize GM-CSFR for Alzheimer’s Disease and Brain Injury – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
RTL-551 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecules to Block TRPC3 for Acute Brain Injury – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecules to Inhibit Caspase-2 for Neonatal Brain Injury – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Synthetic Peptide to Inhibit Factor II for Thrombosis, Restenosis and Brain Injury – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Brain Injury – Recent Pipeline Updates 38
Brain Injury – Dormant Projects 40
Brain Injury – Discontinued Products 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43